Fractyl Health, Inc. GUTS
0.81 USD -0.07 (-7.84%)
At closeNov 13, 2026, 6:55 AM EST
0.96 +0.15 +18.58%
Pre-market · Nov 13, 6:55 AM ET
0.81 Day range 0.905
0.80 52-week range 29.34
- YTD
- -96.92%
- 1 year
- -94.01%
News
seekingalpha.com Fractyl Health, Inc. (GUTS) Q3 2026 Earnings Call Transcript Fractyl Health, Inc. (GUTS) Q3 2026 Earnings Call Transcript
benzinga.com Fractyl Health Q3 EPS $(1.07) Beats $(1.51) Estimate Fractyl Health (NASDAQ:GUTS) reported quarterly losses of $(1.07) per share which beat the analyst consensus estimate of $(1.51) by 29.14 percent. This is a 87.44 percent increase over losses of…
defenseworld.net Fractyl Health, Inc. (NASDAQ:GUTS) Stock Has Consensus Price Target of $50.25 According to Brokerages Shares of Fractyl Health, Inc. (NASDAQ: GUTS - Get Free Report) have been assigned a consensus recommendation of "Hold" from the five brokerages that are presently covering the company, Marketbeat…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Karyopharm Therapeutics (NASDAQ:KPTI) stock moved upwards by 10.0% to $0.04 during Monday's after-market session. The company's market cap stands at $1.2 million. Fractyl Health (NASDAQ:GUTS)…
globenewswire.com Fractyl Health to Report Third Quarter 2026 Financial Results and Provide Business Updates on November 12, 2026 BURLINGTON, Mass., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a clinical-stage metabolic therapeutics company focused on pioneering novel…
benzinga.com Fractyl Health Expands Revita Patent Portfolio Ahead Of Planned FDA De Novo Submission Fractyl Health, Inc. (NASDAQ:GUTS) (the Company or Fractyl), a clinical-stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D), today…
benzinga.com Fractyl Health Announces Heightened Focus On Advancing Revita Toward Potential FDA Marketing Authorization And Commercialization In Post-GLP-1 Weight Maintenance Following positive topline six-month REMAIN-1 pivotal results, Revita advancing toward planned FDA De Novo submission in late Q4 2026 and anticipated 12-month pivotal data readout in Q1 2027Workforce…- benzinga.com Canaccord Genuity Maintains Buy on Fractyl Health, Lowers Price Target to $39 Canaccord Genuity analyst Whitney Ijem maintains Fractyl Health (NASDAQ:GUTS) with a Buy and lowers the price target from $96 to $39.
- benzinga.com Morgan Stanley Maintains Equal-Weight on Fractyl Health, Lowers Price Target to $4 Morgan Stanley analyst Michael Ulz maintains Fractyl Health (NASDAQ:GUTS) with a Equal-Weight and lowers the price target from $24 to $4.
benzinga.com Crude Oil Jumps 3%; Citizens Financial Earnings Top Views U.S. stocks fell Friday, led by Nasdaq’s 1.86% drop; energy rose, communication services sank. Oil topped $100 as CFG beat earnings estimates.
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers Marker Therapeutics (NASDAQ:MRKR) stock increased by 21.2% to $1.11 during Friday's regular session. The market value of their outstanding shares is at $14.8 million. Alaunos Therapeutics…
benzinga.com Why Fractyl Health Stock Is Sinking Friday Fractyl Health (GUTS) stock sank 50% despite positive REMAIN-1 trial results as class action lawsuit concerns weigh on investors.
benzinga.com Dow Surges 250 Points; M&T Bank Posts Upbeat Q3 Earnings U.S. stocks mixed: Dow +0.48%, Nasdaq -0.65%, S&P -0.05%. Energy rose, tech fell, and M&T Bank beat Q3 estimates; oil eased, gold gained.- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Alaunos Therapeutics (NASDAQ:TCRT) shares increased by 27.9% to $2.79 during Friday's pre-market session. The company's market cap stands at $5.2 million. Picard Medical (AMEX:PMI) stock…
- benzinga.com Fractyl Health’s REMAIN-1 Study Meets Six-Month Co-Primary Endpoint With High Statistical Significance; Demonstrates 80% Retention Of GLP-1 Induced Weight Loss Vs 67% For Sham REMAIN-1 met its six-month co-primary endpoint with high statistical significance (p=0.0023; mITT population); demonstrated 80% retention of GLP-1 induced weight loss vs 67% for sham32% of Revita®…
benzinga.com Fractyl Health Q2 EPS $(0.16) Misses $(0.13) Estimate Fractyl Health (NASDAQ:GUTS) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 71.93 percent increase over losses of…
benzinga.com Fractyl Health Helps Maintain Weight After Stopping Popular Obesity Drugs, Stock Soars Fractyl Health reported one-year REMAIN-1 data showing Revita reduced weight regain after GLP-1 therapy with favorable safety results.- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers China Pharma Holding (AMEX:CPHI) shares moved upwards by 67.6% to $1.03 during Wednesday's regular session. The market value of their outstanding shares is at $24.9 million. Conexeu Sciences…
benzinga.com Fractyl Health Announces One-Year Results From Its REMAIN-1 Midpoint Cohort; Results Reinforce Potential Of Revita DMR System To Become First Durable Therapy For Post-GLP-1 Weight Maintenance Key Findings:Dose-dependent durability confirmed at one year: In the full modified intention-to-treat (mITT) population (N=45), a single Revita procedure reduced weight regain by approximately 40%…- benzinga.com HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a Buy and maintains $8 price target.
- benzinga.com Fractyl Health Announces 1-Yr Results From Open-Label REVEAL-1 Cohort; Participants Retained ~78% Of GLP-1 Induced Total Body Weight Loss One Year After Discontinuation And Single Revita Procedure Participants retained ~78% of GLP-1 induced total body weight loss one year after discontinuation and a single Revita procedure5.3% mean weight change observed with Revita (n=15); published…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com Fractyl Health Q1 2026 Earnings Call: Complete Transcript 
benzinga.com Fractyl Health Q1 EPS $0.06 Beats $(0.16) Estimate Fractyl Health (NASDAQ:GUTS) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.16) by 137.5 percent. This is a 112.24 percent increase over losses of…
benzinga.com Earnings Scheduled For May 12, 2026 
benzinga.com Fractyl Health Receives Clinical Trial Application Authorization In Netherlands To Initiate Phase 1/2 First-in-human Study Of RJVA-001, Expects To Start Dosing And Report Preliminary Data In 2H of 2026 Authorization advances Fractyl Health to a dual clinical-stage company, with Revita in pivotal development for post-GLP-1 weight maintenance and Rejuva entering first-in-human studies for type 2…- benzinga.com HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a Buy and maintains $8 price target.
- benzinga.com Earnings Scheduled For March 24, 2026
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com US Stocks Mixed; Tesla Posts Upbeat Q4 Earnings - benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Lightwave Logic, Kyverna Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session 
benzinga.com Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com Earnings Scheduled For November 12, 2025
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The company's market cap stands at $4.5 million.
benzinga.com This Oddity Tech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - benzinga.com Earnings Scheduled For August 12, 2025
benzinga.com Nasdaq Surges 1%; Uber Sales Top Estimates 
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session 
benzinga.com US Stocks Edge Higher; McDonald's Posts Upbeat Earnings - benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga.com Earnings Scheduled For May 13, 2025